Disease Information & Support


The Word:


Generic name Pegaspargase
Pronunciation peg-AS-par-jase
Brand name(s), other common name(s) Oncaspar®, PEG-L-asparaginase
Drug type  Enzyme that prevents cancer cells from surviving
How the drug is given Intravenously (IV)

Pegaspargase is FDA approved in combination with other chemotherapy medications to treat people who have acute lymphoblastic leukemia (ALL).

Side effects needing medical attention: Abdominal or stomach pain; blurry vision; constipation; dry mouth and skin; fatigue; increased hunger or thirst; increased need to urinate; nausea; rash; unexplained weight loss; vomiting.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, January 26, 2015